Revealing on April 30: Are You Ready for the Upcoming Election Surprise?
Here is the latest financial fact sheet of LUPIN. For more details, see the LUPIN quarterly results and LUPIN share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.6 |
No. of shares | m | 455.75 |
1 Week | % | -0.3 |
1 Month | % | -1.5 |
1 Year | % | 126.3 |
52 week H/L | Rs | 1,703.8/680.4 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
LUPIN EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 986 | 882 | 1,122 | 1,268 | 799 | |
Low | Rs | 720 | 505 | 576 | 679 | 583 | |
Sales per share (Unadj.) | Rs | 324.1 | 339.4 | 334.2 | 361.0 | 365.8 | |
Earnings per share (Unadj.) | Rs | 11.5 | -8.8 | 27.1 | -33.2 | 9.8 | |
Diluted earnings per share | Rs | 11.4 | -8.8 | 26.9 | -33.1 | 9.8 | |
Cash flow per share (Unadj.) | Rs | 30.2 | 12.6 | 46.6 | 3.3 | 29.2 | |
Dividends per share (Unadj.) | Rs | 5.00 | 6.00 | 6.50 | 4.00 | 4.00 | |
Adj. dividends per share | Rs | 4.96 | 5.96 | 6.47 | 3.99 | 3.99 | |
Avg Dividend yield | % | 0.6 | 0.9 | 0.8 | 0.4 | 0.6 | |
Book value per share (Unadj.) | Rs | 298.9 | 272.0 | 300.1 | 263.9 | 270.7 | |
Adj. book value per share | Rs | 296.7 | 270.4 | 298.7 | 263.1 | 270.2 | |
Shares outstanding (eoy) | m | 452.49 | 453.00 | 453.68 | 454.48 | 454.98 | |
Price / Sales ratio | x | 2.6 | 2.0 | 2.5 | 2.7 | 1.9 | |
Avg P/E ratio | x | 74.1 | -78.6 | 31.4 | -29.3 | 70.2 | |
P/CF ratio (eoy) | x | 28.2 | 55.1 | 18.2 | 296.1 | 23.7 | |
Price / Book Value ratio | x | 2.9 | 2.5 | 2.8 | 3.7 | 2.6 | |
Dividend payout | % | 43.4 | -68.0 | 24.0 | -12.0 | 40.7 | |
Avg Mkt Cap | Rs m | 386,068 | 314,199 | 385,072 | 442,238 | 314,381 | |
Total wages/salary | Rs m | 27,702 | 29,868 | 28,259 | 29,893 | 30,872 |
LUPIN INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 146,646 | 153,748 | 151,630 | 164,055 | 166,417 | |
Other income | Rs m | 3,330 | 4,838 | 1,363 | 2,137 | 1,509 | |
Total revenues | Rs m | 149,976 | 158,585 | 152,993 | 166,192 | 167,926 | |
Gross profit | Rs m | 22,245 | 16,067 | 25,682 | 2,156 | 17,206 | |
Depreciation | Rs m | 8,461 | 9,702 | 8,874 | 16,587 | 8,807 | |
Interest | Rs m | 3,025 | 3,630 | 1,406 | 1,428 | 2,743 | |
Profit before tax | Rs m | 14,090 | 7,572 | 16,765 | -13,722 | 7,165 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 8,879 | 11,571 | 4,485 | 1,372 | 2,688 | |
Profit after tax | Rs m | 5,210 | -3,999 | 12,279 | -15,094 | 4,477 | |
Gross profit margin | % | 15.2 | 10.5 | 16.9 | 1.3 | 10.3 | |
Effective tax rate | % | 63.0 | 152.8 | 26.8 | -10.0 | 37.5 | |
Net profit margin | % | 3.6 | -2.6 | 8.1 | -9.2 | 2.7 |
LUPIN BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 138,536 | 154,132 | 139,864 | 124,577 | 124,513 | |
Current liabilities | Rs m | 61,299 | 92,252 | 84,361 | 82,764 | 92,654 | |
Net working cap to sales | % | 52.7 | 40.2 | 36.6 | 25.5 | 19.1 | |
Current ratio | x | 2.3 | 1.7 | 1.7 | 1.5 | 1.3 | |
Inventory Days | Days | 68 | 68 | 69 | 33 | 26 | |
Debtors Days | Days | 128 | 129 | 108 | 95 | 98 | |
Net fixed assets | Rs m | 133,618 | 93,963 | 94,439 | 91,938 | 103,490 | |
Share capital | Rs m | 905 | 906 | 907 | 909 | 910 | |
"Free" reserves | Rs m | 134,333 | 122,314 | 135,229 | 119,006 | 122,246 | |
Net worth | Rs m | 135,238 | 123,220 | 136,136 | 119,915 | 123,156 | |
Long term debt | Rs m | 66,417 | 17,933 | 161 | 1,419 | 275 | |
Total assets | Rs m | 272,154 | 248,095 | 234,302 | 216,515 | 228,003 | |
Interest coverage | x | 5.7 | 3.1 | 12.9 | -8.6 | 3.6 | |
Debt to equity ratio | x | 0.5 | 0.1 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.5 | 0.6 | 0.6 | 0.8 | 0.7 | |
Return on assets | % | 3.0 | -0.1 | 5.8 | -6.3 | 3.2 | |
Return on equity | % | 3.9 | -3.2 | 9.0 | -12.6 | 3.6 | |
Return on capital | % | 8.5 | 7.9 | 13.3 | -10.1 | 8.0 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 59,414 | 51,450 | 51,027 | 53,594 | 48,057 | |
Fx outflow | Rs m | 22,282 | 19,470 | 21,081 | 38,143 | 21,752 | |
Net fx | Rs m | 37,132 | 31,980 | 29,946 | 15,451 | 26,306 |
LUPIN CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 16,660 | 14,688 | 18,218 | 3,673 | 18,972 | |
From Investments | Rs m | -32,825 | 11,070 | -12,396 | 12,922 | -12,868 | |
From Financial Activity | Rs m | 7,441 | -8,906 | -18,853 | -15,723 | -3,373 | |
Net Cashflow | Rs m | -8,724 | 16,853 | -13,031 | 872 | 2,732 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Manju D Gupta | COMP SEC: R V Satam | YEAR OF INC: 1983 | BSE CODE: 500257 | FV (Rs): 2 | DIV YIELD (%): 0.3 |
Read: LUPIN 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare LUPIN With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Indian share markets continued the momentum as the session progressed and ended the higher.